Filing Flows

Filing Flows › Consumer Staples › Colgate Palmolive (CL)

Colgate Palmolive (CL) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Oct 30, 2026 · Colgate Palmolive (CL) Q3 2026 earnings results →

Q3 2026 Revenue up 5% year over year to $5.4B · 14¢ of every $1 of revenue kept as net profit · operating margin 20.3%

Colgate Palmolive made $5.4B in Q3 2026 (+5% Y/Y). Operating margin 20.3%, net earnings $751M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 30, 2026.

Revenue$5.4B
Year over year+5%
Operating margin20.3%
Net earnings$751M
Operating cash flow$1.2B

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

Colgate Palmolive Q3 2026 revenue breakdown: Sankey diagram of revenue, costs, profit and cash flow
Colgate Palmolive Q3 2026 revenue breakdown — free to use with credit and a link (terms). Share on X
Embed this chart on your site

Free to use with the credit line. Click a box to select the code.

What changed this quarter

Revenue was $5.4B in Q3 2026, up 5% year over year and roughly flat from the previous quarter.

Gross margin was 60.2%, up 0.8 points from Q3 2025. Operating profit was $1.1B, a 20.3% margin (down 0.4 points year over year). Of the extra revenue versus Q3 2025, 12% reached operating profit, below the 21% margin then. Operating expenses grew 8% against revenue growth of 5%. The fastest-growing cost line was Other operating costs (+79%). Net earnings were $0.75B, up 2% year over year. The effective tax rate was 23.6%.

Operating cash flow was $1.2B (down 7% year over year), 150% of net income including minority interests. Non-cash charges added back $0.16B of depreciation and amortization and $0.06B of share-based compensation. Working capital and other items added $0.17B. Capital expenditures of $0.13B left free cash flow of $1.0B.

Quarterly history

Colgate Palmolive revenue by quarterColgate Palmolive revenue by quarter$4.9BQ1 2025$5.1BQ2 2025$5.1BQ3 2025$5.2BQ4 2025$5.3BQ1 2026$5.4BQ2 2026$5.4BQ3 2026
Colgate Palmolive net earnings by quarterColgate Palmolive net earnings by quarter$690MQ1 2025$743MQ2 2025$735MQ3 2025−$5.0MQ4 2025$646MQ1 2026$693MQ2 2026$751MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QOct 30, 2026$5.4B+5%20.3%$751M$1.2B
Q2 202610-QJul 31, 2026$5.4B+5%19.0%$693M$995M
Q1 202610-QMay 1, 2026$5.3B+8%18.1%$646M$747M
Q4 202510-KFeb 23, 2026$5.2B+6%1.8%−$5.0M$1.5B
Q3 202510-QOct 31, 2025$5.1B+2%20.6%$735M$1.3B
Q2 202510-QAug 1, 2025$5.1B+1%21.1%$743M$884M
Q1 202510-QApr 25, 2025$4.9B-3%21.9%$690M$600M

Charts

Colgate Palmolive: revenue growth, year over year and quarter over quarterColgate Palmolive: revenue growth, year over year and quarter over quarterY/YQ/Q-3%Q1 2025+1%+4%Q2 2025+2%+0%Q3 2025+6%+2%Q4 2025+8%+2%Q1 2026+5%+1%Q2 2026+5%+0%Q3 2026
Latest (Q3 2026): Y/Y +5%, Q/Q +0%.
Colgate Palmolive: where the cash came from (+) and went (−), TTM to Q3 2026Colgate Palmolive: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$4.4BDividends−$1.8BBuybacks−$1.3BCapital spending−$577MOther financing−$484MCash drawn (+) / kept (−)−$248MShares issued$196MNet borrowing (+) / repaid (−)−$181MOther investing$93.0MExchange rates−$1.0M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Colgate Palmolive: profit against cash, quarter by quarterColgate Palmolive: profit against cash, quarter by quarterNet incomeOperating cash flow$779M$1.3BQ4 2024$726M$600MQ1 2025$773M$884MQ2 2025$766M$1.3BQ3 2025−$5.0M$1.5BQ4 2025$681M$747MQ1 2026$719M$995MQ2 2026$779M$1.2BQ3 2026
Latest (Q3 2026): Net income $779M, Operating cash flow $1.2B.
Colgate Palmolive: diluted shares by fiscal yearColgate Palmolive: diluted shares by fiscal year859MFY2020848MFY2021839MFY2022829MFY2023823MFY2024811MFY2025
-5.6% since FY2020: buybacks shrank the count.
Colgate Palmolive: long-term debt falling due (FY2025)Colgate Palmolive: long-term debt falling due (FY2025)$1.1B2026$523M2027$615M2028$591M2029$500M2030$4.5BLater
Cash $1.3B, short-term investments $107M, long-term debt $7.8B at 2025-12-31.
Colgate Palmolive in its industry: growth against margin (15 companies, SIC 2844)Colgate Palmolive in its industry: growth against margin (15 companies, SIC 2844)revenue growth, year over year →↑ operating marginmedian +3%median 7%KVUEELCOTYEPCELFIPARSLSNAXILYCBDUGBNKKDQWSKARXSHFHCL (+5%, 20%)
Perfumes, Cosmetics & Other Toilet Preparations; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Sells to

About Colgate Palmolive

Colgate-Palmolive Company (together with its subsidiaries, “we,” “us,” “our,” the “Company” or “Colgate-Palmolive”) is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet. To achieve our business and financial objectives and deliver peer-leading performance and total shareholder return, we are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.

In its own words, from its 10-K, filed Feb 23, 2026.

Colgate Palmolive against its Perfumes, Cosmetics & Other Toilet Preparations peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +5% against the peers' median +2%. Operating margin: 20.3% against the peers' median 11.0%.

CompanyQuarterRevenueY/YOp. margin
CL Colgate PalmoliveQ3 2026$5.4B+5%20.3%
KVUE KenvueQ3 2026$3.9B+3%18.2%
EL Estee Lauder CompaniesQ1 FY27$3.7B+7%11.0%
COTY CotyQ1 FY27$1.6B-1%11.0%
EPC Edgewell Personal CareQ3 FY26$570M+2%4.4%
ELF e.l.f. BeautyQ2 FY27$521M+51%10.1%
IPAR InterparfumsQ3 2026$430M0%27.4%
SLSN SolesenceQ2 2026$15.3M-25%0.8%
AXIL Axil BrandsQ1 FY27$6.1M-11%7.2%

Source: Colgate Palmolive 10-Q on SEC EDGAR · CIK 21665 · Perfumes, Cosmetics & Other Toilet Preparations

13F: who owns CL and who is buying

Largest holders of CL (13F)Largest holders of CL (13F)Vanguard Group$6.6BBlackRock$6.4BVanguard Capital Management LLC$4.8BState Street$4.3BPrice T Rowe Associates$2.6BVanguard Portfolio Management LLC$2.2BGeode Capital Management, LLC$2.1BMorgan Stanley$2.0BFirst Eagle Investment Management…$1.5BBank of New York Mellon$1.2B
Funds' net buying of CL by quarter (13F)Funds' net buying of CL by quarter (13F)−$172M2024-09−$264M2024-12−$427M2025-03$52.2M2025-06−$123M2025-09−$346M2025-12$845M2026-03−$338M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on CL

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare CL with

中文版：高露洁（CL）财报

Español · Français